Literature DB >> 17133642

Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium.

Alok S Mehta1, Elke Saile, Wei Zhong, Therese Buskas, Russell Carlson, Elmar Kannenberg, Yvonne Reed, Conrad P Quinn, Geert-Jan Boons.   

Abstract

The glycoprotein BclA is an important constituent of the exosporium of Bacillus anthracis spores. This glycoprotein is substituted with an oligosaccharide composed of a beta-L-rhamnoside substituted with the previously unknown terminal saccharide, 2-O-methyl-4-(3-hydroxy-3-methylbutanamido)-4,6-dideoxy-D-glucopyranose, also referred to as anthrose. Anthrose has not been found in spores of B. cereus and B. thuringiensis, making it a potential species-specific marker for B. anthracis. In order to study the antigenicity of anthrose, efficient syntheses of an anthrose-containing trisaccharide and a series of structurally related analogues were developed. The analogues lacked either the methyl ether at C-2 or contained modified C-4 amino functionalities of anthrose. The synthetic compounds were equipped with an aminopropyl spacer to facilitate conjugation to the carrier proteins mariculture Keyhole Limpet Hemocyanin (mcKLH) and bovine serum albumin (BSA). Serum antibodies of rabbits immunized with live or irradiated spores of B. anthracis Sterne 34F(2) were able to recognize the synthetic trisaccharide-mcKLH conjugate. The specificity of the interaction was confirmed by competitive inhibition with the free- and BSA-conjugated trisaccharides. Inhibition using the trisaccharide analogues demonstrated that the isovaleric acid moiety of anthrose is an important structural motif for antibody recognition. These data demonstrate that 1) anthrose is a specific antigenic determinant of the B. anthracis Sterne spore; 2) this antigen is presented to the immune system of rabbits receiving the anthrax live-spore vaccine; 3) synthetic analogues of the oligosaccharide retain the antigenic structure; and 4) the antigenic region is localized to specific terminal groups of the oligosaccharide. Collectively these data provide an important proof-of-concept step in the synthesis and development of spore-specific reagents for detection and targeting of non-protein structures in B. anthracis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133642     DOI: 10.1002/chem.200601245

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  21 in total

1.  Characterization of the enzymes encoded by the anthrose biosynthetic operon of Bacillus anthracis.

Authors:  Shengli Dong; Sylvia A McPherson; Yun Wang; Mei Li; Pengfei Wang; Charles L Turnbough; David G Pritchard
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

2.  Glycosylation of BclA Glycoprotein from Bacillus cereus and Bacillus anthracis Exosporium Is Domain-specific.

Authors:  Emmanuel Maes; Frederic Krzewinski; Estelle Garenaux; Yannick Lequette; Bernadette Coddeville; Xavier Trivelli; Annette Ronse; Christine Faille; Yann Guerardel
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

3.  Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface-associated anthrose-containing oligosaccharide.

Authors:  Marco Tamborrini; Mark Bauer; Miriam Bolz; Angaya Maho; Matthias A Oberli; Daniel B Werz; Esther Schelling; Jakob Zinsstag; Peter H Seeberger; Joachim Frey; Gerd Pluschke
Journal:  J Bacteriol       Date:  2011-05-13       Impact factor: 3.490

4.  De novo asymmetric synthesis of oligo-rhamno di- and tri-saccharides related to the anthrax tetrasaccharide.

Authors:  Hua-Yu Leo Wang; Haibing Guo; George A O'Doherty
Journal:  Tetrahedron       Date:  2013-04-22       Impact factor: 2.457

5.  Antibody responses to a spore carbohydrate antigen as a marker of nonfatal inhalation anthrax in rhesus macaques.

Authors:  Elke Saile; Geert-Jan Boons; Therese Buskas; Russell W Carlson; Elmar L Kannenberg; John R Barr; Anne E Boyer; Maribel Gallegos-Candela; Conrad P Quinn
Journal:  Clin Vaccine Immunol       Date:  2011-03-09

6.  Identification and characterization of glycoproteins on the spore surface of Clostridium difficile.

Authors:  Philippa C R Strong; Kelly M Fulton; Annie Aubry; Simon Foote; Susan M Twine; Susan M Logan
Journal:  J Bacteriol       Date:  2014-05-09       Impact factor: 3.490

7.  Chemical synthesis and immunological properties of oligosaccharides derived from the vegetative cell wall of Bacillus anthracis.

Authors:  Mahalakshmi Vasan; Jana Rauvolfova; Margreet A Wolfert; Christine Leoff; Elmar L Kannenberg; Conrad P Quinn; Russell W Carlson; Geert-Jan Boons
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

8.  Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Haijing Hu; Stephen H Leppla; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

9.  Secondary cell wall polysaccharides of Bacillus anthracis are antigens that contain specific epitopes which cross-react with three pathogenic Bacillus cereus strains that caused severe disease, and other epitopes common to all the Bacillus cereus strains tested.

Authors:  Christine Leoff; Elke Saile; Jana Rauvolfova; Conrad P Quinn; Alex R Hoffmaster; Wei Zhong; Alok S Mehta; Geert-Jan Boons; Russell W Carlson; Elmar L Kannenberg
Journal:  Glycobiology       Date:  2009-03-06       Impact factor: 4.313

10.  Synthesis of the antigenic tetrasaccharide side chain from the major glycoprotein of Bacillus anthracis exosporium.

Authors:  David Crich; Olga Vinogradova
Journal:  J Org Chem       Date:  2007-07-28       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.